MedPath

Glucocorticoid Injection in Patients With Lumbar Radicular Pain

Phase 4
Completed
Conditions
Radiculopathy Lumbar
Interventions
Other: Placebo
Drug: Glucocorticoids
Registration Number
NCT05571046
Lead Sponsor
Cukurova University
Brief Summary

The purpose of this study is to demonstrate the efficacy of intramuscular betamethasone injection on pain and other clinical parameters in patients with radicular pain due to lumbar disc herniation. The investigators also aimed to determine the effects on electrophysiological findings.

Detailed Description

Low back pain is an important health problem that causes difficulties in daily living activities, loss of work performance and disability. Some patients with low back pain have radicular symptoms due to intervertebral disc herniation. Lumbar radiculopathy is characterized by radiating buttock and leg pain in a lumbar nerve root distribution.

The pathophysiology of radiculopathy is related to compression of the nerve, as well as the local release of inflammatory cytokines. Systemic corticosteroids have been used for treatment of lumbar radicular pain for a long time. The effects of corticosteroids are related to their anti-inflammatory effects, which may help reduce swelling and related compression on the affected nerve. Corticosteroids can be used systemically (i.e. oral, intravenous, or intramuscular routes) or administered directly into spinal structures through injections.

In the current study, the investigators aimed to demonstrate the efficacy of intramuscular betamethasone injection on pain, disability and health related quality of life in patients with lumbar radicular pain due to disc herniation. The investigators also aimed to determine the effects on electrophysiological findings.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients aged between 18 and 65 years old with acute (less than 6 weeks) lumbar radicular pain due to intervertebral disc herniation.
  • Neurological findings such as sensory, motor and reflex abnormality matching the L4, L5 or S1 nerve distribution.
  • Patients who confirmed to have root compression (radiculopathy) by electrophysiological investigations.
Exclusion Criteria
  • Contraindication for steroid usage (acute infection, uncontrolled diabetes and hypertension, severe cardiac failure), hypersensitivity to steroids
  • Acute trauma
  • Inflammatory low back pain
  • Indications for neurosurgery (pronounced motor weakness or cauda equina syndrome)
  • Lumbar spinal stenosis
  • History of back surgery, history of steroid injection in the last 3 months
  • Pregnancy, lactation
  • Malignancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo injectionPlaceboIntramuscular saline (%0.9 isotonic sodium chloride)
Glucocorticoid injectionGlucocorticoidsIntramuscular glucocorticoid (5 mg betamethasone dipropionate and 2 mg betamethasone sodium phosphate)
Primary Outcome Measures
NameTimeMethod
Lumbar radicular painMonth 3

Visual analog

(VAS, min-max values: 0-100, higher scores mean a worse outcome)

DisabilityMonth 3

Oswestry Disability Index

(ODI, min-max values: 0-100, higher scores mean a worse outcome)

Health related quality of LifeMonth 3

Nottingham Health Profile (NHP, 6 subscales, for each subscale min-max values: 0-100, higher scores mean a worse outcome)

Secondary Outcome Measures
NameTimeMethod
Electrophysiological evaluation (Sensory NCS)Month 1

Sensory nerve conduction study (m/s)

Electrophysiological evaluation (F wave)Month 1

F wave (m/s)

Electrophysiological evaluation (H reflex)Month 1

H reflex (m/s)

Electrophysiological evaluation (Motor NCS)Month 1

Motor nerve conduction study (m/s)

Trial Locations

Locations (1)

Cukurova University

🇹🇷

Adana, Turkey

© Copyright 2025. All Rights Reserved by MedPath